Czech National Bank Acquires 1,884 Shares of Cencora, Inc. $COR

Czech National Bank lifted its holdings in Cencora, Inc. (NYSE:COR) by 3.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 51,124 shares of the company’s stock after purchasing an additional 1,884 shares during the period. Czech National Bank’s holdings in Cencora were worth $17,267,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Pensionfund Sabic acquired a new stake in shares of Cencora in the fourth quarter worth about $1,621,000. PFW Advisors LLC acquired a new position in shares of Cencora during the 4th quarter valued at about $654,000. Founders Grove Wealth Partners LLC raised its stake in shares of Cencora by 6.5% in the 4th quarter. Founders Grove Wealth Partners LLC now owns 684 shares of the company’s stock valued at $231,000 after acquiring an additional 42 shares in the last quarter. Daymark Wealth Partners LLC lifted its holdings in Cencora by 3.5% in the 4th quarter. Daymark Wealth Partners LLC now owns 1,189 shares of the company’s stock worth $402,000 after purchasing an additional 40 shares during the last quarter. Finally, Quantum Financial Advisors LLC acquired a new stake in Cencora in the 4th quarter worth approximately $202,000. 97.52% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have commented on COR shares. Barclays increased their price target on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a report on Friday, February 13th. Wall Street Zen cut shares of Cencora from a “buy” rating to a “hold” rating in a research note on Friday, November 28th. Bank of America decreased their price objective on shares of Cencora from $380.00 to $360.00 and set a “neutral” rating for the company in a report on Monday, January 5th. Jefferies Financial Group upgraded shares of Cencora from an “underperform” rating to a “buy” rating in a research note on Thursday, January 22nd. Finally, Weiss Ratings upgraded shares of Cencora from a “hold (c+)” rating to a “buy (b)” rating in a report on Thursday, February 5th. Twelve investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Cencora presently has an average rating of “Moderate Buy” and a consensus price target of $403.17.

Insider Activity at Cencora

In related news, CEO Robert P. Mauch sold 5,096 shares of the firm’s stock in a transaction on Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total value of $1,807,704.08. Following the completion of the transaction, the chief executive officer directly owned 66,726 shares of the company’s stock, valued at $23,669,713.98. This trade represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.38% of the company’s stock.

Cencora Stock Down 2.2%

NYSE COR opened at $318.00 on Friday. Cencora, Inc. has a twelve month low of $267.40 and a twelve month high of $377.54. The stock has a market cap of $61.86 billion, a PE ratio of 38.22, a PEG ratio of 1.51 and a beta of 0.68. The firm has a 50-day simple moving average of $352.91 and a 200 day simple moving average of $340.41. The company has a debt-to-equity ratio of 3.62, a quick ratio of 0.51 and a current ratio of 0.92.

Cencora (NYSE:COR) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.04 by $0.04. The firm had revenue of $85.93 billion for the quarter, compared to analyst estimates of $86.12 billion. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The company’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same period in the previous year, the company posted $3.73 earnings per share. On average, research analysts forecast that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were given a dividend of $0.60 per share. The ex-dividend date was Friday, February 13th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. Cencora’s payout ratio is currently 28.85%.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.